Effects of Dexmedetomidine on the Incidence of Agitation and Pain Severity After Traumatic Nasal Surgeries

Document Type : Original Article

Authors

1 Assistant Professor of Anesthesiology, Department of Anesthesiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

2 Anesthesiologist, Department of Anesthesiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

3 Associate Professor of Otorhinolaryngology, Head and Neck Surgery, Department of Otorhinolaryngology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

10.5281/zenodo.21954883
Abstract
Introduction: Conventional agents such as opioids and benzodiazepines may control symptoms but can impair recovery and pose airway-related risks. Dexmedetomidine offers sedative, analgesic, and sympatholytic benefits with minimal respiratory depression. The aim of this trial was to evaluate intraoperative dexmedetomidine for reducing emergence agitation and postoperative pain after traumatic nasal surgery.

Material and methods: This prospective, double-blind randomized controlled trial at Imam Reza Hospital included 60 patients undergoing traumatic nasal surgery, randomized equally to receive either intraoperative dexmedetomidine or saline placebo. Dexmedetomidine was administered as a 1 µg/kg loading dose followed by a 0.5 µg/kg/h infusion. Primary outcomes were postoperative agitation and pain severity, while secondary outcomes included hemodynamic changes, recovery duration, rescue analgesic use, and adverse events.

Results: Dexmedetomidine significantly reduced postoperative emergence agitation and pain scores at all assessed time points compared with placebo. It also attenuated heart rate and mean arterial pressure during early recovery without affecting oxygen saturation. Although dexmedetomidine prolonged extubation time and PACU stay, it did not significantly increase major adverse events and was associated with a lower incidence of postoperative shivering.

Conclusion: In conclusion, intraoperative infusion of dexmedetomidine during traumatic nasal surgery significantly attenuates emergence agitation and mitigates postoperative pain severity, while ensuring superior hemodynamic stability in the early recovery phase.

Graphical Abstract

Effects of Dexmedetomidine on the Incidence of Agitation and Pain Severity After Traumatic Nasal Surgeries

Keywords

Subjects

[1]                Hu, R., Liu, J. X., & Jiang, H. (2013). Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: A double-blinded randomized controlled trial. Journal of Anesthesia, *27*(2), 211–217.
[2]                Jo, Y. Y., Kim, H. S., Lee, K. C., Chang, Y. J., Shin, Y., & Kwak, H. J. (2017). The effect of intraoperative dexmedetomidine on hemodynamic responses during emergence from nasotracheal intubation after oral surgery. Medicine, *96*(22), e6661.
[3]                Ham, S. Y., Kim, J. E., Park, C., Shin, M. J., & Shim, Y. H. (2014). Dexmedetomidine does not reduce emergence agitation in adults following orthognathic surgery. Acta Anaesthesiologica Scandinavica, *58*(8), 955–960.
[4]                Lu, Y., Fang, P. P., Yu, Y. Q., Cheng, X. Q., Feng, X. M., Wong, G. T. C., Maze, M., Liu, X. S., & POGF Study Collaborators. (2021). Effect of intraoperative dexmedetomidine on recovery of gastrointestinal function after abdominal surgery in older adults: A randomized clinical trial. JAMA Network Open, *4*(10), e2128886.
[5]                Reichert, M., Willis, F., Post, S., Schneider, M., Vilz, T., Willis, M., & Hecker, A. (2024). Pharmacologic prevention and therapy of postoperative paralytic ileus after gastrointestinal cancer surgery: Systematic review and meta-analysis. International Journal of Surgery, *110*(7), 4329–4341.
[6]                Wu, J., Han, Y., Lu, Y., Zhuang, Y., Li, W., & Jia, J. (2022). Perioperative low dose dexmedetomidine and its effect on the visibility of the surgical field for middle ear microsurgery: A randomized controlled trial. Frontiers in Pharmacology, *13*, 760916.
[7]                Hassan, H., Shado, R., Novo Pereira, I., Mistry, M., & Craig, D. (2024). Efficacy and cost analysis of intravenous conscious sedation for long oral surgery procedures. British Journal of Oral and Maxillofacial Surgery, *62*(6), 523–538.
[8]                Cossovel, F., Trombetta, A., Ramondo, A., Riccio, G., Ronfani, L., Saccari, A., Cozzi, G., & Barbi, E. (2022). Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam. Italian Journal of Pediatrics, *48*, 5.
[9]                Zhang, Y., Li, C., Shi, J., Gong, Y., Zeng, T., Lin, M., & Zhang, X. (2020). Comparison of dexmedetomidine with midazolam for dental surgery: A systematic review and meta-analysis. Medicine, *99*(45), e22288.
[10]             Abernethy, E. K., & Aly, E. H. (2024). Postoperative ileus after minimally invasive colorectal surgery: A summary of current strategies for prevention and management. Digestive Surgery, *41*(3), 79–91.
[11]             Chandra, P. K., Patel, D. K., Mohanty, R. K., Kulmi, M., & Makkad, R. S. (2025). Evaluating efficiency of propofol and dexmedetomidine for hypotensive anesthesia in ENT operations. Journal of Pharmacy and Bioallied Sciences, *17*(Suppl 2), S1424–S1426.
[12]             Begum, A., Ram, R. M., & Prasad, M. (2025). An unusual surgical complication: Slipped molar lodged in vocal cords and its anesthetic management. Journal of Oral Biology and Craniofacial Research, *15*(1), 22–24.
[13]             Knackstedt, R., & Patel, N. (2020). Enhanced recovery protocol after fronto-orbital advancement reduces transfusions, narcotic usage, and length of stay. Plastic and Reconstructive Surgery—Global Open, *8*(12), e3205.
[14]             Aldanyowi, S. N. (2023). Novel techniques for musculoskeletal pain management after orthopedic surgical procedures: A systematic review. Life, *13*(12), 2351.
[15]             Jason, A. S., Sundaram, G. A., J, P., Kumar, S. P., & Krishnan, M. (2023). Comparison of the efficacy of midazolam and dexmedetomidine as sedative agents in third molar surgery. Cureus, *15*(10), e49477.